144 related articles for article (PubMed ID: 32938553)
1. The European evidence-based guidelines on pancreatic cystic neoplasms (PCN) in clinical practice: The development of relative and absolute indications for surgery during prospective IPMN surveillance.
Vaalavuo Y; Siiki A; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
Pancreatology; 2020 Oct; 20(7):1393-1398. PubMed ID: 32938553
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
[TBL] [Abstract][Full Text] [Related]
3. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
5. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
6. [Limited pancreatic resections for intraductal papillary mucinous neoplasm].
Blanc B; Sauvanet A; Couvelard A; Pessaux P; Dokmak S; Vullierme MP; Lévy P; Ruszniewski P; Belghiti J
J Chir (Paris); 2008; 145(6):568-78. PubMed ID: 19106888
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of primary surveillance for intraductal papillary mucinous neoplasm.
Cauley CE; Waters JA; Dumas RP; Meyer JE; Al-Haddad MA; DeWitt JM; Lillemoe KD; Schmidt CM
J Gastrointest Surg; 2012 Feb; 16(2):258-67; discussion 266. PubMed ID: 22089952
[TBL] [Abstract][Full Text] [Related]
8. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
9. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia.
van Huijgevoort NCM; Hoogenboom SAM; Lekkerkerker SJ; Busch OR; Del Chiaro M; Fockens P; Somers I; Verheij J; Voermans RP; Besselink MG; van Hooft JE
Pancreatology; 2023 Apr; 23(3):251-257. PubMed ID: 36805049
[TBL] [Abstract][Full Text] [Related]
11. [Intraductal papillary mucinous neoplasms of the pancreas: pro surgical therapy--pro surveillance].
Uhl W; Belyaev O; Herzog T; Mueller CA; Seelig M; Schmidt W; Hohenberger W; Ellenrieder V
Z Gastroenterol; 2008 Nov; 46(11):1290-7. PubMed ID: 19012202
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasm--when to resect?
Waters JA; Schmidt CM
Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
[TBL] [Abstract][Full Text] [Related]
13. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines.
Pérez-Cuadrado-Robles E; Uribarri-González L; Borbath I; Vila JJ; López-López S; Deprez PH
Dig Liver Dis; 2019 Jun; 51(6):882-886. PubMed ID: 30591368
[TBL] [Abstract][Full Text] [Related]
14. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
15. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
[TBL] [Abstract][Full Text] [Related]
17. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
18. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
20. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms.
Roch AM; Parikh JA; Al-Haddad MA; DeWitt JM; Ceppa EP; House MG; Nakeeb A; Schmidt CM
Surgery; 2014 Oct; 156(4):923-9. PubMed ID: 25239347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
